April 19-20,2018
Day one morning-Global Industry trends

Day one afternoon to Day two

Stream A -Drug Substance

Stream B --Formulation Design and development

Stream C-- Analytical Development and Support

Stream D-- Regulatory Planning and BE Studies Session

Related Event
DDF Asia 2013



Zhejiang JiuzhouPharmaceutical Co., Ltd. (Stock Code: 603456)was founded in 1973, focusing on R&D, manufactureand sales of pharmaceutical APIs and intermediates, custom contract (CRO/CDMO) as one of the high-tech enterprises.

Its CDMO division is equipped with independent functions across R&D,manufacture and sales.Our main production base is Zhejiang Raybow Pharmaceutical Co. Ltd. which undertakesprojects from preclinical R&D phase to commercial manufacturingbusiness. It has passed many audits conducted by competent regulatory authorities worldwide through China, America, Europe etc. and itis an international standard cGMP production base.

Address: Waisha Road 99,Jiaojiang,Taizhou,Zhejiang,318000,P.R.China

Download Brochure

  • Protech Pharmaservices Corporation (PPC)
  • Proswell Medical Company
  • Beijing LEVA Pharmaceutical Co. Ltd
  • Nikyang Enterprise Limited
  • Mettler-Toledo
  • Clarivate Analytics
  • EAG
  • Bruker (Beijing) Scientific Technology Co.,Ltd
  • Green Griffith
  • Beijing Scinovo Laboratories Ltd
  • kc
  • hengxing
  • CTSmed
  • NeoTrident
  • E-Zheng
  • Sundia MediTech
  • Tegent
  • 博志研新
  • DKSH
  • ViaClinical Ltd
Media Partner
  • yg
  • swwy
  • bio1000
  • phex
  • pharma china
  • Insight
  • dxy
  • bio-equip
  • GBI
  • PharmaVision
  • ipt
  • Bioon
  • Lingmed
Contact Us

Luke Xia